Over the past 50 years, Israel became the international epicenter of medical pot, researching cures for diseases ranging from autism to diabetes. Israel was where THC, the principal psychoactive constituent of cannabis, was first discovered. Israel was among the first countries to legalize medicinal cannabis use, and is one of just three countries with a government-supported medical cannabis program. Israel has the world’s largest number of clinical trials testing the benefits of medicinal cannabis, and is the destination for medical cannabis research and development.
Israeli researchers are using pot in clinical trials to alleviate symptoms in a range of diseases from autism to diabetes. Breath of Life Pharma (BOL), is about to open the world’s largest medical marijuana production, research and development facility. With one million square feet of cultivation fields, a 35,000-square-foot production plant, and 30,000 square feet of grow rooms and labs, Breath of Life, BOL Pharma has been pioneering the creation of the medical cannabis industry.
The tour included:
- Dr. Tamir Gedo – CEO of BOL Pharma, one of Israel’s pioneers driving the worldwide medical cannabis industry.
- Dr. Adi Aran – Director of the Neuro-pediatric unit, Shaare Zedek Medical Center Jerusalem whose latest research involves treating the symptoms of autism using medical marijuana
- Dr. Itamar Raz – head of the Israel National Diabetes Council and long time director of the diabetes unit at Hadassah University Medical Center
- Mgr. Yuval Landschaft – Director of the Medical Cannabis Unit in the Ministry of Health
- Light lunch
- Tour of the production area and view of the greenhouses.
The greenhouses are not yet set up for plants. During this tour journalists will overlook where the plants will be housed. There will be no photos of cannabis or the research labs.